Media

In the press

Coverage of Endo Axiom's mission to replace injected insulin with a daily oral pill, and the spin-out of our oral nanotechnology platform from the University of Sydney.

Mirage News 4 April 2023

Oral insulin nanocarrier breakthrough could transform diabetes care

Read article →
BioSpectrum Asia 5 April 2023

Australian startup Endo Axiom advances oral insulin platform

Read article →
The University of Sydney 5 April 2023

Sydney researchers spin out company to deliver insulin in a pill

Read article →
TechNode Global 6 April 2023

Endo Axiom emerges to commercialise oral insulin nanotechnology

Read article →
MTPConnect 14 April 2023

Endo Axiom tackles one of diabetes' biggest challenges: needle-free insulin

Read article →